- Home
- QIPT vs LUCD Comparison
QIPT vs LUCD Comparison
Compare QIPT & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- LUCD
- Stock Information
- Founded
- QIPT 1993
- LUCD 2018
- Country
- QIPT United States
- LUCD United States
- Employees
- QIPT N/A
- LUCD N/A
- Industry
- QIPT
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- QIPT
- LUCD Health Care
- Exchange
- QIPT Nasdaq
- LUCD Nasdaq
- Market Cap
- QIPT 92.2M
- LUCD 105.0M
- IPO Year
- QIPT N/A
- LUCD 2021
- Fundamental
- Price
- QIPT $2.66
- LUCD $1.05
- Analyst Decision
- QIPT Buy
- LUCD Strong Buy
- Analyst Count
- QIPT 2
- LUCD 5
- Target Price
- QIPT $3.15
- LUCD $3.65
- AVG Volume (30 Days)
- QIPT 789.4K
- LUCD 1.6M
- Earning Date
- QIPT 08-11-2025
- LUCD 11-12-2025
- Dividend Yield
- QIPT N/A
- LUCD N/A
- EPS Growth
- QIPT N/A
- LUCD N/A
- EPS
- QIPT N/A
- LUCD N/A
- Revenue
- QIPT $238,378,000.00
- LUCD $4,360,000.00
- Revenue This Year
- QIPT N/A
- LUCD $22.80
- Revenue Next Year
- QIPT $27.59
- LUCD $221.19
- P/E Ratio
- QIPT N/A
- LUCD N/A
- Revenue Growth
- QIPT N/A
- LUCD 14.74
- 52 Week Low
- QIPT $1.35
- LUCD $0.73
- 52 Week High
- QIPT $3.27
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- QIPT 65.83
- LUCD 43.28
- Support Level
- QIPT $2.53
- LUCD $1.01
- Resistance Level
- QIPT $2.65
- LUCD $1.09
- Average True Range (ATR)
- QIPT 0.09
- LUCD 0.10
- MACD
- QIPT 0.00
- LUCD -0.03
- Stochastic Oscillator
- QIPT 85.13
- LUCD 5.74
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.